I didn’t hear the entire call. Joe said private company? If do there goes my theory of Tappimune/ Markers. In what I did hear- Joe once again did a great job. His discussion on improvements in shareholder equity is spot on. I wish I had time to call in to ask more about Olaregen and any pending research potential with Neon Therapeutics. I’ll have to listen tomorrow because I missed the Olaregen part,